http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2041268-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
filingDate 1991-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be32573a0e64b02aaa2c9990057242f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c187050e952d66c07bd2be64a57bfa72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e508e766f6ef0ebe2ae9d50fdac8b5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc35261b457fd22462a0a0fcc5fcb88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_947ca37acddaed8b0d45052234d87e8c
publicationDate 1991-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2041268-A1
titleOfInvention Peptides with a bradykinin-antagonistic action
abstract Peptides with a bradykinin-antagonistic action Peptides of the formula I A-B-C-E-F-K-(D)-Tic-G-M-F'-I ~~(I) in which A is hydrogen, alkyl, alkanoyl, alkoxycarbonyl, alkylsulfonyl, cycloalkyl, aryl, arylsulfonyl, heteroaryl or an amino acid, each of which can optionally be substi-tuted, B is a basic amino acid, C is a di- or tripeptide E is the residue of an aliphatic or alicyclic-aliphatic amino acid, F is, independently of one another, an amino acid which is optionally substituted in the side chain or a direct bond, G is an amino acid, F' is as defined as F, can be -NH-(CH2)2-8 or optionally a direct bond, I is -OH, -NH2 or -NHC2H5, and K is a radical -NH-(CH2)1-4-CO- or is a direct bond, have a bradykinin-antagonistic action. Their therapeutic uses comprise all pathological states which are mediated, induced or assisted by bradykinin or bradykinin-related peptides. The peptides of the formula I are prepared by known methods of peptide synthesis.
priorityDate 1990-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8WUW1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID424957
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID478666
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449808
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID288001
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID460916
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ91VR8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16644
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3827

Total number of triples: 41.